WMB enters the week looking like a consensus trade — and that convergence is exactly what makes the setup worth watching.
The stock gained 6.2% over the past week to close at $79.40, adding to an 11.6% one-month rally. The Street has been chasing it higher. Morgan Stanley just raised its target from $90 to $98 this morning, maintaining Overweight. That follows a string of upward revisions from UBS, TD Cowen, Citigroup, Scotiabank, and RBC Capital — all raising targets since early May, all keeping positive ratings. Goldman Sachs upgraded to Buy back in April. The direction is unmistakably bullish, with the mean Street target now at $82.33. Given the stock is already trading through that consensus figure at $79.40, Morgan Stanley's $98 is the outlier doing the most narrative work right now.
The borrow market tells a calmer story. Short interest is a modest 1.6% of free float — not the kind of level that drives a squeeze narrative. It has risen roughly 22% over the past month in share terms, but that still leaves it well within normal territory for a large infrastructure name. Borrow costs have actually fallen 26% over the week to just 0.33% annually, and availability is about as loose as it gets — around 60 shares available in the lending pool for every one currently borrowed. There is no short pressure here worth flagging. Options positioning is a touch more defensive: the put/call ratio has climbed to 0.96, running about 1.6 standard deviations above its 20-day average of 0.72. That is not extreme — the 52-week high is 1.45 — but it does suggest some options buyers have shifted toward hedging the rally rather than extending it.
The bull case rests on fundamentals that the Street finds increasingly compelling. WMB's Q1 cash flow print reinforced confidence in dividend sustainability, and the company's role as a critical natural gas infrastructure provider gives it durable fee-based cash flows as LNG demand grows. Factor scores add texture: the dividend score ranks at the 96th percentile, a standout for income-oriented holders. Analyst recommendation divergence from consensus sits at the 87th percentile, meaning the Street is more uniformly positive than for nearly nine in ten comparable names. EPS surprise history is solid at the 70th percentile. The valuation is not cheap — EV/EBITDA is running near 14.9x, up roughly 0.1x over the past month as the stock has re-rated — but the bear case centres less on valuation and more on execution risk: a large project backlog may require partner financing, and reliance on derivative instruments to manage commodity price exposure adds complexity.
The insider picture provides a gentle counterweight. Every recent trade in the data is a sale. The CFO sold 50,000 shares at $75.37 on May 6 for $3.8 million — the largest individual transaction in the recent window. The COO followed with a 12,000-share sale at $76.49 on May 14. The General Counsel and two Senior Vice Presidents have also sold smaller amounts across March and April. Net insider activity over 90 days is marginally positive in share terms, but the recent cadence of sales — occurring as the stock climbs — is worth noting, even if none of these transactions are individually alarming in size. Institutional holders, by contrast, have been adding: BlackRock added over 4 million shares and State Street over 5 million in the last reported period to April 30.
Peers moved broadly in tandem this week. KMI gained 5.7% and TRGP led the group with 8.2%. The midstream complex is in collective re-rating mode. Q2 earnings are not due until July 30, which leaves WMB trading almost entirely on sentiment and macro energy flows in the near term.
With the stock now above the Street's mean target and only Morgan Stanley's raised $98 offering meaningful upside against the current price, the next move in analyst coverage — whether further upgrades push consensus higher, or whether any firm blinks on valuation — is the key thing to follow.
See the live data behind this article on ORTEX.
Open WMB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.